PAPEL DA SARCOPENIA COMO PREDITOR DE MORTALIDADE EM PACIENTES GRAVES: O QUE DIZ A LITERATURA

Authors

  • Vanessa Magalhães Faculdade de Enfermagem Nova Esperança - FACENE/RN
  • Igor Menescal Jales
  • Débora Yane Oliveira de Medeiros
  • Yasmin Lima de Farias Cavalcante
  • Allan Michel Bezerra Lima
  • Priscila Barbosa Tabuso Fiuza
  • Renata Silveira Maciel
  • Maíra Dias de Oliveira Campos
  • Fernanda Queiroz Rêgo
  • Thais Mendonça da Costa
  • Marília Cristina Gomes de Lima
  • Patricia Assis Frota
  • Renata Dantas Amorim Rosado
  • Maria Mauricélia Lopes de Almeida
  • Alessandra Sousa Celestino de Paula Lima

DOI:

https://doi.org/10.36557/pbpc.v4i1.314

Keywords:

Sarcopenia, Mortalidade, Cuidado Intensivo, Fatores Precipitantes

Abstract

Introduction: Sarcopenia, characterized by the progressive and generalized loss of muscle mass, strength, and function, is a multifactorial condition that primarily affects the elderly but can also occur in younger individuals under conditions of intense metabolic stress, such as critical illnesses, systemic inflammation, and prolonged immobility. In recent years, a growing body of evidence has pointed to a direct association between sarcopenia and adverse clinical outcomes in critically ill patients. Therefore, this article reviews the existing literature on the topic, aiming to evaluate the correlation between sarcopenia and negative outcomes, including mortality, in critically ill patients, while highlighting the underlying mechanisms and clinical implications. Methodology: This is an integrative review on the proposed topic, based on full-text scientific articles in Portuguese or English, retrieved from databases such as PubMed, SciELO, the Virtual Health Library, and others, within the time frame of 2010 to 2024. Health Sciences Descriptors (DeCS) were used to select the studies most relevant to the research. Results and Discussion: The literature review revealed consistent evidence that sarcopenia is an independent predictor of mortality in critically ill patients, particularly in populations admitted to intensive care units (ICUs). The included studies emphasize the importance of early assessment of sarcopenia as part of clinical management, as well as the association between reduced skeletal muscle mass and adverse outcomes such as hospital mortality, prolonged length of stay, and increased postoperative complications. Conclusion: The findings of this review suggest that the identification and management of sarcopenia should be incorporated into routine practices in critical care settings. In this context, future strategies should focus on developing accessible and standardized tools for sarcopenia assessment, in addition to studies investigating specific interventions for high-risk populations.

Downloads

Download data is not yet available.

References

Bone, A. E., Hepgul, N., Kon, S. S. C., Maddocks, M. (2017). Sarcopenia and frailty in chronic respiratory disease: Lessons from gerontology. The European Respiratory Journal, 50(5), 1701208. https://doi.org/10.1183/13993003.01208-2017

Cederholm, T., Jensen, G. L., Correia, M., et al. (2017). GLIM criteria for the diagnosis of malnutrition – A consensus report from the global clinical nutrition community. Journal of Cachexia, Sarcopenia and Muscle, 8(2), 207-217. https://doi.org/10.1002/jcsm.12296

Chen, L. K., Woo, J., Assantachai, P., et al. (2020). Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. Journal of the American Medical Directors Association, 21(3), 300-307.e2. https://doi.org/10.1016/j.jamda.2019.12.012

Cruz-Jentoft, A. J., Bahat, G., Bauer, J., et al. (2019). Sarcopenia: Revised European consensus on definition and diagnosis. Age and Ageing, 48(1), 16-31. https://doi.org/10.1093/ageing/afy169

Heyland, D. K., Wischmeyer, P. E. (2011). Nutrition therapy in the critically ill: A systematic review and meta-analysis. JAMA, 305(5), 506-513. https://doi.org/10.1001/jama.2011.50

Janssen, I., Heymsfield, S. B., Ross, R. (2004). Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. Journal of the American Geriatrics Society, 50(5), 889-896. https://doi.org/10.1046/j.1532-5415.2002.50216.x

Lieffers, J. R., Bathe, O. F., Fassbender, K., et al. (2012). Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. British Journal of Cancer, 107(6), 931-936. https://doi.org/10.1038/bjc.2012.350

Moore, C. J., Granger, C. L., McDonald, C. F., et al. (2013). The incidence of muscle wasting during acute exacerbations of chronic obstructive pulmonary disease (COPD). Thorax, 68(5), 419-420. https://doi.org/10.1136/thoraxjnl-2012-203146

Mourtzakis, M., Prado, C. M., Lieffers, J. R., et al. (2008). A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Applied Physiology, Nutrition, and Metabolism, 33(5), 997-1006. https://doi.org/10.1139/H08-075

Puthucheary, Z. A., Rawal, J., McPhail, M., et al. (2013). Acute skeletal muscle wasting in critical illness. JAMA, 310(15), 1591-1600. https://doi.org/10.1001/jama.2013.278481

Published

2025-02-04

How to Cite

MAGALHÃES, Vanessa et al. PAPEL DA SARCOPENIA COMO PREDITOR DE MORTALIDADE EM PACIENTES GRAVES: O QUE DIZ A LITERATURA . Periódicos Brasil. Pesquisa Científica, Macapá, Brasil, v. 4, n. 1, p. 2527–2534, 2025. DOI: 10.36557/pbpc.v4i1.314. Disponível em: https://periodicosbrasil.emnuvens.com.br/revista/article/view/314. Acesso em: 7 jun. 2025.